These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1313876)

  • 1. Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists.
    Harper RW; Herron DK; Bollinger NG; Sawyer JS; Baldwin RF; Roman CR; Rinkema LE; Fleisch JH
    J Med Chem; 1992 Apr; 35(7):1191-200. PubMed ID: 1313876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonists.
    Sawyer JS; Baldwin RF; Rinkema LE; Roman CR; Fleisch JH
    J Med Chem; 1992 Apr; 35(7):1200-9. PubMed ID: 1313877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.
    Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH
    J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647.
    Marshall WS; Sigmund SK; Whitesitt CA; Lifer SL; Roman CR; Rinkema LE; Hahn RA; Fleisch JH
    Agents Actions; 1989 Jun; 27(3-4):309-12. PubMed ID: 2552762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 4. Addition of chromone moiety enhances leukotriene D4 receptor binding affinity.
    Huang FC; Galemmo RA; Poli GB; Learn KS; Morrissette MM; Johnson WH; Dankulich WP; Campbell HF; Carnathan GW; VanInwegen RG
    J Med Chem; 1991 May; 34(5):1704-7. PubMed ID: 1851845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
    J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDL 28,753, an agonist of LTD4 but an antagonist of LTC4 in longitudinal muscle of guinea pig ileum.
    Gieske TH; Sabol JS; Raddatz R
    J Pharmacol Exp Ther; 1990 Jul; 254(1):192-7. PubMed ID: 2164091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
    Youssefyeh RD; Magnien E; Lee TD; Chan WK; Lin CJ; Galemmo RA; Johnson WH; Tan J; Campbell HF; Huang FC
    J Med Chem; 1990 Apr; 33(4):1186-94. PubMed ID: 2157009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
    O'Sullivan BP; Mong S
    Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives.
    Dillard RD; Carr FP; McCullough D; Haisch KD; Rinkema LE; Fleisch JH
    J Med Chem; 1987 May; 30(5):911-8. PubMed ID: 3033245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonists.
    Marshall WS; Whitesitt CA; Goodson T; Roman C; Rinkema L; Fleisch JH
    Agents Actions; 1987 Aug; 21(3-4):275-7. PubMed ID: 3687580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid.
    Zamboni R; Belley M; Champion E; Charette L; DeHaven R; Frenette R; Gauthier JY; Jones TR; Leger S; Masson P
    J Med Chem; 1992 Oct; 35(21):3832-44. PubMed ID: 1331447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally restricted leukotriene receptor antagonists: [(octahydro-2-oxo-7-tetradecylidene-2H-1-benzopyran-8-yl)thio]ace tic acids.
    Gieske TH; Sabol JS; Weintraub PM; Raddatz R; Cregge RJ
    Pharmacology; 1990; 40(5):271-6. PubMed ID: 2177202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
    Zwaagstra ME; Timmerman H; van de Stolpe AC; de Kanter FJ; Tamura M; Wada Y; Zhang MQ
    J Med Chem; 1998 Apr; 41(9):1428-38. PubMed ID: 9554876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors.
    Arakida Y; Suwa K; Ohga K; Yokota M; Miyata K; Yamada T; Honda K
    J Pharmacol Exp Ther; 1998 Nov; 287(2):633-9. PubMed ID: 9808690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of LY290324 in the guinea-pig: an orally active, potent and selective cysteinyl leukotriene receptor antagonist.
    Boot JR; Bond A; Thomas KH; O'Brien A; Gilmore J; Todd A
    Eur J Pharmacol; 1993 Jan; 231(1):83-9. PubMed ID: 8383064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency.
    Galemmo RA; Johnson WH; Learn KS; Lee TD; Huang FC; Campbell HF; Youssefyeh R; O'Rourke SV; Schuessler G; Sweeney DM
    J Med Chem; 1990 Oct; 33(10):2828-41. PubMed ID: 2170649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
    Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH
    Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.
    Hahn RA; MacDonald BR; Morgan E; Potts BD; Parli CJ; Rinkema LE; Whitesitt CA; Marshall WS
    J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and contractile activity of new pseudopeptido and thioaromatic analogues of leukotriene D4.
    Niel N; Rechencq E; Muller A; Vidal JP; Escale R; Durand T; Girard JP; Rossi JC; Bonne C
    Prostaglandins; 1992 Jan; 43(1):45-54. PubMed ID: 1312247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.